Overview

Phase II Study of Chemotherapy and Pamidronate for the Treatment of Newly Diagnosed Osteosarcoma

Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
This study is designed to test the safety and feasibility of the simultaneous administration of a biphosphonate with chemotherapy for the treatment of osteosarcoma in newly diagnosed patients.
Phase:
Phase 2
Details
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Treatments:
Cisplatin
Doxorubicin
Liposomal doxorubicin
Methotrexate